BioMarin CFO steps down; plus Atara, Epirium, Abalos, CytomX and more

By BioCentury Staff | Feb 6, 2020 | 1:24 AM GMT
Editor's note: Updated on Feb 6, 2020 at 2:27 AM GMT

Dan Spiegelman stepped down as EVP and CFO at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to pursue other interests. SVP, Finance and Chief Accounting Officer Brian Mueller will serve as acting CFO as the rare diseases company searches internally and externally for a permanent successor.

Allogeneic T cell therapy company Atara Biotherapeutics Inc. (NASDAQ:ATRA) hired Kristin Yarema

Read the full 558 word article

How to gain access

Continue reading with a
two-week free trial.